A highly statistically significant decrease (p = 0.001) in the expression level of HAND2-AS1 was shown in primary tumors of patients with lymph node metastases compared to non-metastatic tumors (Figure 8a). This evidence concerns the gene HAND2 and metastatic malignant neoplasm in the lymph nodes.